NCT00060996终止3 期
A Randomized Placebo-Controlled, 12-Week Multicenter Study of the Safety and Efficacy of Continuous or Daily Administration of Remodulin® (Treprostinil Sodium) Injection in Patients With CLI With No Planned Revascularization Procedures
United Therapeutics14 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2003年2月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 发起方
- 入组人数
- 30
- 试验地点
- 14
研究概览
简要总结
The purpose of this study is to assess and compare the safety of continuous and daily subcutaneous Remodulin therapy in patients with critical limb ischemia (CLI) with no planned vascular interventional procedures; and to determine the effect of Remodulin on wound healing and treadmill walk distance.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with Stage III or IV critical limb ischemia due to documented peripheral arterial disease with no planned interventional vascular procedures
排除标准
- 未提供
研究者
研究点 (14)
Loading locations...
相似试验
已完成
1 期
Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic DermatitisAtopic DermatitisNCT01385657Regeneron Pharmaceuticals37
已完成
2 期
DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) PathwayGenetic ObesityNCT04963231Rhythm Pharmaceuticals, Inc.164
已完成
3 期
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryVenous ThromboembolismNCT00679588Sanofi4,413
已完成
2 期
Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)Eosinophilic EsophagitisNCT02379052Regeneron Pharmaceuticals47
已完成
1 期
Effect of Teduglutide on Gastric Emptying in Healthy SubjectsHealthy VolunteersNCT01209351Shire36